ダウンロード数: 211

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
bcr-2013-203485.pdf173.82 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorHirota, Keishoen
dc.contributor.authorYasoda, Akihiroen
dc.contributor.authorFujii, Toshihitoen
dc.contributor.authorInagaki, Nobuyaen
dc.contributor.alternative八十田, 明宏ja
dc.date.accessioned2015-08-19T02:42:02Z-
dc.date.available2015-08-19T02:42:02Z-
dc.date.issued2014-03-05-
dc.identifier.issn1757-790X-
dc.identifier.urihttp://hdl.handle.net/2433/199586-
dc.description.abstractA 52-year-old woman with overlap syndrome and interstitial pneumonia underwent immunosuppressive therapy and she was suspected to suffer from pulmonary aspergillosis. Oral voriconazole was initiated, and a rapid elevation of alkaline phosphatase (ALP) occurred after 4 weeks. After 2 months, the patient presented diffuse pain in bilateral skeletal regions, and bone scintigraphy revealed bilateral multiple areas of increased radiotracer uptake. We suspected the skeletal involvement as voriconazole-induced periostitis. Actually, the plasma fluoride level was increased. Voriconazole was replaced with itraconazole, and after 3 weeks, the patient stopped complaining of bone pain concomitant with the decrease in ALP. Voriconazole-induced periostitis is a rare condition but had previously been reported in solid organ or patients with bone marrow transplant who received a long-term voriconazole therapy. Our present case is distinctive of previous ones, because it occurred in a patient with connective tissue disease which had its rapid progression.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBMJ Publishing Groupen
dc.rightsThis article has been accepted for publication in BMJ Case Reports following peer review. The definitive copyedited, typeset version [Keisho Hirota, Akihiro Yasoda, Toshihito Fujii, Nobuya Inagaki. Voriconazole-induced periostitis in a patient with overlap syndromes. BMJ Case Reports 2014; doi:10.1136/bcr-2013-203485] is available online at: http://casereports.bmj.com/content/2014/bcr-2013-203485.en
dc.rightsこの論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。ja
dc.rightsThis is not the published version. Please cite only the published version.en
dc.subject.meshAntifungal Agents/adverse effectsen
dc.subject.meshAntifungal Agents/therapeutic useen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshImmunocompromised Hosten
dc.subject.meshImmunosuppressive Agents/adverse effectsen
dc.subject.meshImmunosuppressive Agents/therapeutic useen
dc.subject.meshMiddle Ageden
dc.subject.meshPeriostitis/chemically induceden
dc.subject.meshPeriostitis/diagnosisen
dc.subject.meshPulmonary Aspergillosis/drug therapyen
dc.subject.meshPulmonary Aspergillosis/immunologyen
dc.subject.meshRheumatic Diseases/complicationsen
dc.subject.meshRheumatic Diseases/drug therapyen
dc.subject.meshVoriconazole/adverse effectsen
dc.subject.meshVoriconazole/therapeutic useen
dc.titleVoriconazole-induced periostitis in a patient with overlap syndromes.en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleBMJ case reportsen
dc.identifier.volume2014-
dc.relation.doi10.1136/bcr-2013-203485-
dc.textversionauthor-
dc.identifier.pmid24599432-
dcterms.accessRightsopen access-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。